Prognostically distinct clinical patterns of systemic lupus erythematosus identified by cluster analysis
- 27 October 2009
- journal article
- Published by SAGE Publications in Lupus
- Vol. 18 (14), 1267-1275
- https://doi.org/10.1177/0961203309345767
Abstract
The objective of this study was to evaluate the patterns of clinical manifestations and their mortality in a large cohort of Chinese patients with systemic lupus erythematosus. The cumulative clinical manifestations of a large group of Chinese systemic lupus erythematosus patients who fulfilled at least four American College of Rheumatology criteria for systemic lupus erythematosus were studied. Patients were divided into distinct groups by using the K-mean cluster analysis. Clinical features, prevalence of proliferative lupus nephritis (World Health Organization class III, IV), autoantibody profile, and treatment data were compared and the standardized mortality ratios were calculated for each cluster of patients. There were 1082 patients included in the study (mean age at systemic lupus erythematosus diagnosis 30.5 years; mean systemic lupus erythematosus duration 10.3 years). Three distinct groups of patients were identified. Cluster 1 (n = 347) was characterized predominantly by mucocutaneous manifestations (malar rash, discoid rash, photosensitivity, oral ulcer) and arthritis but having the lowest prevalence of serositis, hematologic manifestations (hemolytic anemia, leukopenia, and thrombocytopenia), and proliferative lupus nephritis. Patients in cluster 2 (n = 409) had mainly renal and hematological manifestations but having the lowest prevalence of mucocutaneous manifestations. Pulmonary and gastrointestinal manifestations were significantly more frequent in cluster 2 than the other clusters. Cluster 3 patients (n = 326) had the most heterogeneous features. Besides having a high prevalence of mucocutaneous manifestations, serositis and hematologic manifestations, renal involvement, and proliferative lupus nephritis was also most prevalent among the three clusters. Patients in cluster 2 had a much higher standardized mortality ratio [standardized mortality ratio 7.23 (6.7—7.7), p < 0.001] than those in cluster 3 [standardized mortality ratio 1.27 (1.1—1.5), p = 0.005] and cluster 1 [standardized mortality ratio 0.95 (0.5—1.7), p = 0.86]. In conclusion, patients with systemic lupus erythematosus could be clustered into prognostically distinct patterns of clinical manifestations. Lupus (2009) 18, 1267—1275.Keywords
This publication has 22 references indexed in Scilit:
- Systemic lupus erythematosus in Europe at the change of the millennium: Lessons from the “Euro-Lupus Project”Autoimmunity Reviews, 2006
- Lupus in Baltimore: evidence-based ‘clinical pearls’ from the Hopkins Lupus CohortLupus, 2005
- Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?Arthritis & Rheumatism, 2005
- Long-term Survival of Southern Chinese Patients With Systemic Lupus ErythematosusMedicine, 2005
- Contributions of Observational Cohort Studies in Systemic Lupus Erythematosus: The University of Toronto Lupus Clinic ExperienceRheumatic Disease Clinics of North America, 2005
- Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosusAnnals Of The Rheumatic Diseases, 2004
- Clusters of clinical and immunologic features in systemic lupus erythematosus: analysis of 600 patients from a single centerSeminars in Arthritis and Rheumatism, 2004
- A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsetsClinical Rheumatology, 1998
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982